Journal
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 53, Issue 5, Pages 1836-1846Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2018.4542
Keywords
protein kinase C-; atypical protein kinase C inhibitors; prostate cancer; nuclear factor-kappa B; biomarkers
Categories
Funding
- Leo and Anne Albert Charitable Trust [USFF 42-1042]
- Sapphire Foundation for Prostate Cancer [USFF 42-0044]
- Daniel Tanner Foundation [USFF 42-044]
- Frederick H. Leonhardt Foundation [USFF 42-0044]
Ask authors/readers for more resources
Prostate cancer (PC) is the most common type of cancer among men. Aggressive and metastatic PC results in life- threatening tumors, and represents one of the leading causes of mortality in men. Previous studies of atypical protein kinase C isoforms (aPKCs) have highlighted its role in the survival of cultured prostate cells via the nuclear factor (NF)-B pathway. The present study showed that PKC- was overexpressed in PC samples collected from cancer patients but not in non-invasive prostate tissues, indicating PKC- as a possible prognostic biomarker for the progression of prostate carcinogenesis. Immunohistochemical staining further confirmed the association between PKC- and the prostate malignancy. The DU-145 and PC-3 PC cell lines, and the non-neoplastic RWPE-1 prostatic epithelial cell line were cultured and treated with aPKC inhibitors 2-acetyl-1,3-cyclopentanedione (ACPD) and 5-amino-1-(1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide (ICA-1). Western blot data demonstrated that ICA-1 was an effective and specific inhibitor of PKC- and that ACPD inhibited PKC- and PKC-. Furthermore, the two inhibitors significantly decreased malignant cell proliferation and induced apoptosis. The inhibitors showed no significant cytotoxicity towards the RWPE-1 cells, but exhibited cytostatic effects on the DU-145 and PC-3 cells prior to inducing apoptosis. The inhibition of aPKCs significantly reduced the translocation of NF-B to the nucleus. Furthermore, this inhibition promoted apoptosis, reduced signaling for cell survival, and reduced the proliferation of PC cells, whereas the normal prostate epithelial cells were relatively unaffected. Overall, the results suggested that PKC- and PKC- are essential for the progression of PC, and that ACPD and ICA-1 can be effectively used as potential inhibitors in targeted therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available